|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash and cash equivalents | ||||||
| Accounts receivable, net of allowance | ||||||
| Contract acquisition costs | ||||||
| Contract assets, net of allowance | ||||||
| Prepayments and other current assets | ||||||
| Total current assets | ||||||
| Property and equipment, net | ||||||
| Contract acquisition costs, non-current | ||||||
| Contract assets, non-current, net of allowance | ||||||
| Other non-current assets | ||||||
| Goodwill | ||||||
| Intangible assets, net | ||||||
| Total assets | ||||||
| Liabilities and stockholders' equity | ||||||
| Current liabilities | ||||||
| Accounts payable | ||||||
| Accrued expenses and other liabilities | ||||||
| Deferred revenue | ||||||
| Total current liabilities | ||||||
| Deferred tax liabilities, non-current | ||||||
| Other long-term liabilities | ||||||
| Deferred revenue, non-current | ||||||
| Long-term debt, net | ||||||
| Total liabilities | ||||||
| Redeemable convertible units, no par value, unlimited units authorized, 499,052,847 units issued and outstanding as of January 31, 2025; aggregate liquidation preference of $8,100,352 as of January 31, 2025 | ||||||
| Stockholders' equity | ||||||
| Preferred stock, par value of $0.0001 per share; 50,000,000 shares authorized; no shares issued or outstanding as of July 31, 2026 and January 31, 2026 | ||||||
| Common stock, par value of $0.0001 per share; 1,750,000,000 shares authorized; 570,907,856 and 563,781,636 shares issued and outstanding as of July 31, 2026 and January 31, 2026, respectively | ||||||
| Additional paid in capital | ||||||
| Accumulated deficit | ||||||
| Total stockholders' equity | ||||||
| Total liabilities and stockholders' equity |
Loading...
